Clinical Trials Logo

Bulimia Nervosa clinical trials

View clinical trials related to Bulimia Nervosa.

Filter by:

NCT ID: NCT05770947 Recruiting - Bulimia Nervosa Clinical Trials

Cognitive Behavioral Therapy for Adolescents With Bulimia Nervosa and Higher Weight (Online Treatment Study)

Start date: January 24, 2023
Phase: N/A
Study type: Interventional

This study will test the feasibility and acceptability of two treatments for adolescents with higher weight seeking treatment for bulimia nervosa (binge eating and purging, or going to extremes to lose weight).

NCT ID: NCT05753410 Recruiting - Anorexia Nervosa Clinical Trials

App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa. This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further developed, a subsequent study (with a different clinicaltrials.gov identification #) will utilize a randomized control trial design.

NCT ID: NCT05728021 Recruiting - Bulimia Nervosa Clinical Trials

Smartphone-based Aftercare for Inpatients With Bulimia Nervosa

SMART-BN
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Inpatient treatment for patients with bulimia nervosa (BN) is recommended in extreme or severe cases and/or after failure of outpatient treatment and is highly effective. However, a number of patients show symptom increase and relapse after discharge. The aim of this study is to evaluate the efficacy of a guided smartphone-based aftercare intervention following inpatient treatment of patients with BN to support recovery.

NCT ID: NCT05724394 Recruiting - Eating Disorders Clinical Trials

Feasibility Trial of Getting Better Bite by Bite for Eating Disorders

CaGBBB
Start date: March 28, 2023
Phase: N/A
Study type: Interventional

This is a mixed method feasibility randomized controlled trial to explore the feasibility and acceptability of therapist delivered, culturally adapted, manualized Ca-GBBB intervention for Eating Disorders (EDs) - Bulimia Nervosa (BN) and Bing Eating Disorder (BED) in Pakistan.

NCT ID: NCT05614024 Recruiting - Bulimia Nervosa Clinical Trials

Neurofeedback During Eating for Bulimia Nervosa

Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.

NCT ID: NCT05575960 Recruiting - Major Depression Clinical Trials

Interpersonal Psychotherapy for Adolescents and Young Adults

Start date: October 3, 2022
Phase: N/A
Study type: Interventional

The purpose of the project is to study the effectiveness of Interpersonal Psychotherapy (IPT) for adolescents and young adults when applied to depression and eating disorders. Specific aims are to analyze the effects, change mechanisms, predictors, and implementation of IPT for youth. In this four-year project we will include 120 patients with depression and 60 adolescents and young adults with eating disorders. Outcome will be studied using a quasi-experimental multiple-baseline design. Change mechanisms will be studied in the form of mentalizing, emotion regulation, social support, and working alliance session-by-session, and with post-treatment qualitative interviews about the participants' experiences of change. Predictors of effectiveness of IPT for adolescents and young adults will be explored by measuring severity of symptoms, anxiety symptoms, presence and severity of parent-child conflicts, quality of interpersonal relationships, experiences of bullying, and school functioning. The implementation process of IPT for youth will be studied through interviews with adolescents, parents, therapists, co-workers, and local managers. The study is a multi-center study within child and adolescent psychiatric services in Gothenburg and Norrköping using a practice-oriented research strategy which emphasizes close collaboration with clinicians. The project is a collaboration between researchers at Linnaeus University, Linköping University, and University of Gothenburg, and clinicians at the BUP Norrköping and Ätstörningscentrum Barn och Unga Vuxna, Sahlgrenska University Hospital.

NCT ID: NCT05509257 Recruiting - Eating Disorders Clinical Trials

Naltrexone Neuroimaging in Teens With Eating Disorders

NN-RCT
Start date: September 17, 2022
Phase: Early Phase 1
Study type: Interventional

Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation by naltrexone (an opioid antagonist) in pre-defined regions of interest (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex).

NCT ID: NCT05507008 Recruiting - Anorexia Nervosa Clinical Trials

Ketone Supplementation in Eating Disorders

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on electroencephalogram (EEG) measurement. All subjects enrolled in the study will undergo EEG on two consecutive days at the beginning of the study, after active ketone supplementation or placebo drink, matched in taste to the ketone drink. Days will be randomized. Thereafter, all subjects will take the ketone supplementation drink for two weeks, twice daily.

NCT ID: NCT05473013 Recruiting - Bulimia Nervosa Clinical Trials

Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Start date: January 6, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to identify the independent and combined effects of two types of self-monitoring and two types of micro-interventions when combined with standard cognitive behavioral treatment for bulimia nervosa (BN) and binge eating disorder (BED). The primary aims of this study are (1) to evaluate the optimal complexity of Self-Monitoring and Micro-Interventions on eating pathology (at post-treatment and at 6 and 12-month follow-ups and (2) to test the hypotheses that the optimal complexity level of each component is moderated by baseline deficits in self-regulation. The secondary aim will be to test target engagement for each level of complexity for each component, i.e., to test whether higher complexity of each technological components is associated with better rates of therapeutic skill use and acquisition and that improvements in skill use and acquisition are associated with improvements in outcomes. A final exploratory aim will be to quantify the component interaction effects, which may be partially additive (because components overlap and/or there is diminishing return), fully additive, or synergistic (in that component complexities may partially depend on each other).

NCT ID: NCT05385653 Recruiting - Bulimia Nervosa Clinical Trials

Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED)

RevBED
Start date: June 29, 2023
Phase: N/A
Study type: Interventional

Food craving is a major therapeutic issue in Eating Disorders with binge eating: the Bulimia Nervosa and the Binge Eating Disorder (BED). Food craving is linked to compulsive eating and its apprehension is currently based on classic Cognitive and Behavioural Therapies (CBT). However, it remains difficult to induce in therapy and a significant number of patients do not respond to classic CBTs. The development of exposure scenarios for CBT in virtual reality (VR) has allowed a gain in efficacy and in particular therapeutic effects lasting longer after treatment. Nevertheless, the stimuli used are often simple food visuals and insufficiently consider the many factors influencing food craving (physical, psychological, socio-environmental...) and VR immersion is still limited by the use of 3D laptops (fixed) rather than wireless headsets.